The National Center for Biotechnology Information’s designation of p53 as “The Tumor Suppressing Protein” (NIH publication) marks not just a scientific achievement; it serves as an emblematic beacon of hope to all touched by cancer – particularly those currently fighting a battle themselves. What secrets does this protein hold that could alter treatment paths?

Our cells contain an unseen protector known as the p53 gene that, under most conditions, does its job admirably, protecting us against cancer development. But what happens if this gene becomes compromised?

The Role of P53 in Cell Regulation

Under normal conditions, the p53 gene helps to regulate cell division and growth by protecting damaged DNA from being repaired or destroyed. However, if this gene becomes damaged (we’ll discuss ways this could occur in the next section), its ability to perform its task could lead to abnormal cell growth – cancerous ones in particular.

Researchers published in Cancer Cell International (2021) noted: “Mutant p53 proteins possess oncogenic properties, modulating cancer cell proliferation, survival, invasion, and metastasis. In a study published in Cancer Cell International (2021), researchers noted: “Many of these mutant p53 proteins have oncogenic characteristics, and therefore modulate the ability of cancer cells to proliferate, escape apoptosis, invade and metastasize. Because p53 deficiency is so common in human cancer, this protein is an excellent option for cancer treatment.”

Mutations in the P53 Gene and Cancer Development

Mutations of the p53 gene may be caused by multiple factors. Environmental or lifestyle influences as well as genetic predispositions are some common sources. They include:

• Chemical Exposure: Industrial chemicals, tobacco products, and even certain processed foods can all cause mutations of the p53 gene.
• Damaging UV Rays: Excessive exposure to ultraviolet (UV) rays (from either natural sunlight or tanning beds) can damage DNA in our skin cells and result in genetic mutations.
• Radiation Exposure: Prolonged radiation exposure can lead to mutations of the p53 gene resulting in cancerous tumors.
• Viruses: Viruses such as the Human Papillomavirus (HPV) have been shown to negatively alter cells, leading to eventual mutations of p53 genes.
• Inherited Genetic Mutations: Mutations in the p53 gene may be inherited from both parents. While less likely to occur, this phenomenon can significantly increase one’s risk for specific forms of cancer.
• Natural Aging Cycle: As we age, natural processes for repairing DNA become less efficient, leading to accumulation of damage over time that may eventually cause mutations p53 genetic mutations.

NOTE: One risk factor alone does not guarantee a p53 mutation will occur. Many of these factors can interact in complex ways. They may simply indicate an increase in odds.

The Dual Role of P53

Our cells rely on the p53 gene as a guardian to make sure only healthy cells proliferate, protecting us against potential tumor formation and tumor-forming mutations. If cells become damaged, however, p53 either repairs them or instructs them to self-destruct through an apoptotic process called apoptosis — ultimately leading to reduced tumor formation risk.

Mutations that affect the p53 gene compromise its protective functions and cannot repair or eliminate damaged cells effectively. As a result, tumor cells continue to divide unchecked – one key step on their journey toward cancer development and progression. Therefore, maintaining the integrity of this gene is absolutely critical in combatting cancer.

Researchers and Therapeutic Implications

Scientists are making strides toward better understanding how the p53 gene functions and harnessing its resources to prevent mutations from arising within it, or correct existing ones so as to better combat cancer at its early stages. Their goal is to gain more insight into this remarkable protein so as to use its powers more efficiently against tumor development and spread.

Conclusion

The p53 gene plays an essential role in combatting cancer and its mutations can have serious repercussions for health issues. Ongoing research seeking new treatments provides hope. But while we’re waiting for more scientific break-throughs, you can leverage epigenetic principles by the simple act of adopting lifestyle choices that influence genetic expression for a uniquely proactive way of supporting your health and minimizing genetic risks.

*  *  *  *  *

Eat Healthy, Wherever You Are!
Visit the Templeton List

Resources:

Marei HE, Althani A, Afifi N, Hasan A, Caceci T, Pozzoli G, Morrione A, Giordano A, Cenciarelli C. p53 signaling in cancer progression and therapy. Cancer Cell Int. 2021 Dec 24;21(1):703. doi: 10.1186/s12935-021-02396-8. PMID: 34952583; PMCID: PMC8709944.

National Center for Biotechnology Information (US). Genes and Disease [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 1998-. The p53 tumor suppressor protein. Available from: https://www.ncbi.nlm.nih.gov/books/NBK22268/

Lutz W, Nowakowska-Swirta E. Gene p53 mutations, protein p53, and anti-p53 antibodies as biomarkers of cancer process. Int J Occup Med Environ Health. 2002;15(3):209-18. PMID: 12462448.

de Pedro I, Alonso-Lecue P, Sanz-Gómez N, Freije A, Gandarillas A. Sublethal UV irradiation induces squamous differentiation via a p53-independent, DNA damage-mitosis checkpoint. Cell Death Dis. 2018 Oct 25;9(11):1094. doi: 10.1038/s41419-018-1130-8. PMID: 30361544; PMCID: PMC6202398.

Zhang X, Zhang Y. Bladder Cancer and Genetic Mutations. Cell Biochem Biophys. 2015 Sep;73(1):65-9. doi: 10.1007/s12013-015-0574-z. PMID: 27352265.

Little JB. Radiation carcinogenesis. Carcinogenesis. 2000 Mar;21(3):397-404. doi: 10.1093/carcin/21.3.397. PMID: 10688860.
Aloni-Grinstein R, Charni-Natan M, Solomon H, Rotter V. p53 and the Viral Connection: Back into the Future ‡. Cancers (Basel). 2018 Jun 4;10(6):178. doi: 10.3390/cancers10060178. PMID: 29866997; PMCID: PMC6024945.

Dhalla PS, Kaul A, Garcia J, Bapatla A, Khalid R, Armenta-Quiroga AS, Khan S. Comparing the Role of the p53 Gene and Telomerase Enzyme in ‘Accelerated Aging Due to Cancer’: A Literature Review. Cureus. 2020 Oct 4;12(10):e10794. doi: 10.7759/cureus.10794. PMID: 33163298; PMCID: PMC7641464.

Yurgelun MB, Kulke MH, Fuchs CS, Allen BA, Uno H, Hornick JL, Ukaegbu CI, Brais LK, McNamara PG, Mayer RJ, Schrag D, Meyerhardt JA, Ng K, Kidd J, Singh N, Hartman AR, Wenstrup RJ, Syngal S. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer. J Clin Oncol. 2017 Apr 1;35(10):1086-1095. doi: 10.1200/JCO.2016.71.0012. Epub 2017 Jan 30. PMID: 28135145; PMCID: PMC5455355.

Sidransky D, Tokino T, Helzlsouer K, Zehnbauer B, Rausch G, Shelton B, Prestigiacomo L, Vogelstein B, Davidson N. Inherited p53 gene mutations in breast cancer. Cancer Res. 1992 May 15;52(10):2984-6. PMID: 1581912.